Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Chemotherapy-Induced Nausea and Vomiting (CINV) Market from 2024 to 2033?

The chemotherapy-induced nausea and vomiting (CINV) market size has experienced strong growth, expected to grow from $2.69 billion in 2023 to $2.92 billion in 2024, at a CAGR of 8.4%. This growth is driven by increased chemotherapy use, improved antiemetic agents, clinical guidelines, and patient advocacy.

The chemotherapy-induced nausea and vomiting (CINV) market is expected to grow robustly, reaching $3.88 billion by 2028 at a CAGR of 7.4%. Growth factors include personalized medicine, advances in antiemetic agents, telehealth, and remote monitoring. Key trends include combination antiemetic therapies, supportive care services, digital health tools, and survivorship care.

Claim Your Free Sample of the Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13031&type=smp

The rising prevalence of cancer is projected to fuel the growth of the chemotherapy-induced nausea and vomiting (CINV) market. As cancer cases rise, the need for improved CINV management grows, prompting advancements in targeted anti-emetic treatments. The American Cancer Society reported in January 2023 that approximately 1.9 million new cancer cases and 609,820 cancer deaths were expected in the U.S. in 2023. Thus, the increasing incidence of cancer is propelling the CINV market forward.

1) By Form: Injectables, Oral, Transdermal Patches

2) By Drug Class: 5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class

3) By Emetogenic Risk: Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)

4) By Distribution Channel: CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores

5) By Application: Gynecology, Urology, Gastrointestinal Surgery, Other Applications

Companies in the chemotherapy-induced nausea and vomiting (CINV) market are introducing innovative delivery systems like transdermal systems to meet customer needs. In April 2021, Starton Therapeutics Inc. received FDA approval for the STAR-OLZ transdermal delivery system (TDS), designed to treat CINV. This system, providing a multi-day delivery of olanzapine, demonstrated effectiveness in managing nausea better than standard therapies, with trials showing reduced medication usage and acceptable tolerability.

Order Now for Fast Delivery of Your Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report!

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-nausea-and-vomiting-cinv-global-market-report

North America was the largest region in the online charging system (OCS) market in 2023. The regions covered in the online charging system (ocs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Chemotherapy-Induced Nausea and Vomiting (CINV) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the chemotherapy-induced nausea and vomiting (cinv) market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Chemotherapy-Induced Nausea and Vomiting (CINV) Market Include

1. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Executive Summary

2. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segments

3. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size And Template Market Growth Rate

4. Key Chemotherapy-Induced Nausea and Vomiting (CINV) Market Trends

5. Major Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers

……

25. Key Mergers And Acquisitions In The Chemotherapy-Induced Nausea and Vomiting (CINV) Market

26. Top Chemotherapy-Induced Nausea and Vomiting (CINV) Companies

27. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Opportunities And Strategies

28. Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Viral Vectors & Plasmid DNA Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-peripheral-neuropathy-treatment-global-market-report

Chemotherapy-Induced Anemia Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: